CEFODIZIME SODIUM PDF

Cefodizime Sodium ≥96% (HPLC); CAS Number: ; Synonym: 5-Thia azabicyclo[]octenecarboxylic acid. Cefodizime Sodium is a medicine available in a number of countries worldwide. A list of US medications equivalent to Cefodizime Sodium is available on the. The first dose of cefodizime in patients with impaired renal function is the . The sodium content of cefodizime (75 mg/g) should be taken into.

Author: Zulkit Garr
Country: Cyprus
Language: English (Spanish)
Genre: Relationship
Published (Last): 24 February 2018
Pages: 404
PDF File Size: 14.68 Mb
ePub File Size: 4.21 Mb
ISBN: 169-1-78383-391-7
Downloads: 71608
Price: Free* [*Free Regsitration Required]
Uploader: Fenrirn

Dalteparin The therapeutic efficacy of Dalteparin can be decreased when used in combination with Cefotaxime. Meclofenamic acid Cefotaxime may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.

Leucovorin The excretion of Leucovorin can be decreased when combined with Cefotaxime. Lorpiprazole Cefotaxime may decrease the excretion rate of Lorpiprazole which could result sodkum a higher serum level. Sacubitril Cefotaxime may decrease the excretion rate of Sacubitril which could result in a higher serum level.

Vilanterol Cefotaxime may decrease the excretion rate of Skdium which could result in a higher serum level. Chromium nicotinate Cefotaxime may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.

Sodkum Cefotaxime cefodizie decrease the excretion rate of Vortioxetine which could result in a higher serum level. Thiopental The therapeutic efficacy of Thiopental can be decreased when used in combination with Cefotaxime.

Sulfasalazine The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Sulfasalazine. Budesonide Cefotaxime may decrease the excretion rate of Budesonide which could result in a higher serum level.

Cefotaxime

Iopromide Cefotaxime may decrease the excretion rate of Iopromide which could result in a higher serum level. Estradiol cypionate Cefotaxime may decrease the soduum rate of Estradiol cypionate which could result in a higher serum level.

  EL CASTIGO DE LA BELLA DURMIENTE ANNE RICE PDF

Metharbital The therapeutic efficacy of Metharbital can be decreased when used in combination with Cefotaxime. Cefodizime demonstrated superior clinical cefodisime that what could be predicted from its in vitro experimental results. Letaxaban The therapeutic efficacy of Letaxaban can be decreased when used in combination with Cefotaxime.

Cefodizime

Santa Cruz Biotechnology, Inc. Droxidopa Cefotaxime may decrease the excretion rate of Droxidopa which could result in a higher serum level. Benserazide Cefotaxime may decrease the excretion rate of Benserazide which could result in a higher serum ccefodizime. Isoniazid Cefotaxime may decrease the excretion rate of Isoniazid which could result in a higher serum level. Magnesium carbonate Cefotaxime may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.

Epirizole The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Epirizole. Cefaloridine The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Cephaloridine.

Cefodizime sodium | C20H18N6Na2O7S4 – PubChem

Amikacin The risk or fefodizime of nephrotoxicity can be increased when Amikacin is combined with Cefotaxime. Technetium Tcm pyrophosphate Cefotaxime may decrease the excretion rate of Technetium Tcm pyrophosphate cefoizime could result in a higher serum level. Choline salicylate Cefotaxime may decrease the excretion rate of Choline salicylate which could result in a higher serum level. Tiaprofenic acid The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Tiaprofenic acid.

Nabumetone The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefotaxime. Views Read Edit View history. Subscribe to free Drugs.

  ARTICUENTOS COMPLETOS JUAN JOSE MILLAS PDF

Cefodizime Sodium | C20H18N6Na2O7S4 | ChemSpider

Paramethadione The therapeutic efficacy of Paramethadione can be decreased when used in combination with Cefotaxime. Pirlindole Cefotaxime may decrease the excretion rate of Pirlindole which could result in a higher serum level. Ximelagatran The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Cefotaxime. Azelaic acid Cefotaxime may decrease sodiu excretion rate of Azelaic acid which could result in a higher serum level.

Rosuvastatin The excretion of Rosuvastatin can be decreased when combined with Cefotaxime. Sibutramine Cefotaxime may decrease the excretion rate of Sibutramine which could result in a higher serum level. Levofloxacin Cefotaxime may decrease the excretion rate of Levofloxacin which could result in a higher serum level. Levocetirizine Cefotaxime may decrease the excretion rate of Levocetirizine which could result in a higher serum level.

Dimercaprol Cefotaxime may decrease the excretion rate of Dimercaprol which could result in a higher serum level. Nafamostat The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefotaxime. Doxycycline Cefotaxime may decrease the excretion rate of Doxycycline which could result in a higher serum level. Felbinac The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Felbinac.

Ssodium The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Sulindac.